Strōma Medical Corporation
Michael Orozco is a seasoned professional in the field of research and development, currently serving as Senior Director at Strōma Medical Corp. since March 2021 and as VP of Optics & Lasers at FemtoMetrix, Inc. since March 2018. Prior experience includes roles as Director of R&D at Femto Blanc from August 2017 to March 2021 and Senior Scientist at Alcon LenSx, Inc. from July 2011 to August 2017. Notable achievements include the development of a custom Semi-conductor Saturable Absorber Mirror (SeSAM) at significantly reduced costs and leading a team to create an ultra-stable femtosecond oscillator at a competitive price. Michael Orozco holds a PhD in Chemistry from the University of Michigan and a Bachelor's degree in Chemistry from UC Irvine.
This person is not in any teams
This person is not in any offices
Strōma Medical Corporation
1 followers
Strōma Medical Corporation is a clinical-stage medical device company that has developed a patented technology to change human eye color, comprised of a laser with specific parameters and proprietary eye-tracking software. The non-invasive treatments do not require general anesthesia, require minimal recovery time, take less than 30 seconds pertreatment per eye, and will result in dark eyes changing to a radiant, natural-looking hazel, gray/blue, blue, or green eye color.The company was founded in 2009 and is based in Irvine, California.